Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer

NCT00463515 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT00463515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer
Lead sponsor
University Hospital, Antwerp
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
November 30, 2006
Enrollment
77
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell-lung cancer